EUVIMED · CrossrefZeitschrift
JHEP Reports
ISSN 2589-5559 · Elsevier BV
Neueste Artikel
A pilot study of plasma cell-free DNA fragmentomics in gallbladder cancer
Adjuvant capecitabine in resected biliary tract cancer: A real-world data from the BILCAP-Real study (ACABi multicenter cohort)
Combined anti-PD-1 with irreversible electroporation relieves immunosuppression and reduces hepatocellular carcinoma regrowth
Medical therapy of MASLD – consequences of the paradigm shift from histology to non-invasive tests
Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis
Multi-ancestry sequencing analysis in 293,141 participants identifies predisposition DNA-repair genes associated with HCC risk
MiR-122 regulates liver tolerance
Magnitude of portal pressure reduction and clinical outcomes in randomized trials
Chronic liver disease-related osteoporosis: From mechanisms to precision intervention
High HBV antigen levels drive loss of vaccine-induced CD8+ T-cell function in carrier mice over time
Spatial transcriptomics reveal impaired metabolic liver zonation in acute-on-chronic liver failure
Intestinal barrier dysfunction assessed by confocal laser endomicroscopy correlates with cirrhosis severity and clinical outcomes
Biomarkers associated with efficacy of first-line nivolumab vs. sorafenib in advanced hepatocellular carcinoma: Results from the CheckMate 459 phase III trial
Novel 3D models for β-catenin-driven liver cancers
Aligned ELF and VCTE cut-offs facilitate risk staging in patients with metabolic dysfunction-associated steatohepatitis
Modeling liver cancer molecular and histological features by CRISPR editing of porcine hepatocytes
Defining clinically relevant myosteatosis in patients with cirrhosis
Prognostic role of the Child-Turcotte-Pugh classification and ALBI grade in patients without cirrhosis and hepatocellular carcinoma
Hepatitis C RNA prevalence before and during broad access to direct-acting antivirals in people with HIV across six countries
Hyperinflammatory reprogramming marks the transition from MASH to HCC
Seladelpar improves liver stiffness in PBC: ASSURE interim analysis
Sex differences in MASLD and fitness improvement during a weight loss intervention for adolescents living with obesity
Corrigendum to ‘Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management’ [JHEP Reports (2026) 8; 101798; https://doi.org/10.1016/j.jhepr.2026.101798]
The landscape of hepatocellular carcinoma recurrence after liver transplantation: A nationwide 14-year study
Peripartum ALT flares predict earlier postpartum HBeAg clearance in highly viremic HBV-infected women: A long-term follow-up study
Time-restricted eating, liver health, and fecal microbiota in adults with overweight or obesity: A randomized controlled trial
The use of FGF21 analogues in MASH and MASH cirrhosis – metabolic master regulators or liver-specific mechanisms?
Integrative multi-omics analysis identifies stellate cell-derived complement component 7 as a predictor of fibrosis and liver-related events in MASLD
A dynamic prognostic and adaptive treatment framework for advanced biliary tract cancer
Gender differences in stigma and care avoidance among people living with MASLD: An international survey
EUVIMED